Spots Global Cancer Trial Database for Open-Label Extension to Evaluate the Long-Term Safety, Tolerability and Analgesic Efficacy

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Open-Label Extension to Evaluate the Long-Term Safety, Tolerability and Analgesic Efficacy

Official Title: An Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability and Analgesic Efficacy of Numorphan® CR (Oxymorphone HCL Controlled Release) in Subjects With Cancer Pain or Chronic Lower Back Pain.

Study ID: NCT00904280

Conditions

Cancers, Pain

Lower Back Pain

Interventions

Oxymorphone ER

Study Description

Brief Summary: The purpose of this study is to evaluate the long-term safety and tolerability of oxymorphone ER as an analgesic in cancer and lower back pain subjects having chronic moderate to severe pain.

Detailed Description: